[176 Pages Report] The global contrast media market is projected to reach USD 5.53 Billion by 2022 from an estimated USD 4.40 Billion in 2016, growing at a CAGR of 3.9% during the forecast period. Growth in the contrast media market can primarily be attributed to factors such as increasing number of approvals for contrast agents and increasing number of public & private diagnostic centers. The increasing number of research and funding activities for research of contrast agents and their applications provide immense opportunities for players, in the contrast media market.

Objectives of the Study:

To define, describe, segment, and forecast the global contrast media market on the basis of product, modality, route of administration, indication, application, and region

To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

To strategically analyze micromarkets with respect to the individual growth trends, future prospects, and contributions to the overall market

To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To profile the key players and comprehensively analyze their product portfolios, market shares, and core competencies in the global contrast media market

To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

To track and analyze competitive developments such as market developments (regulatory and product approvals); agreements, collaborations, contracts, and partnerships; expansions; mergers and acquisitions; and other strategies (divestments, grants, and website launches).

Research Methodology:

Top-down and bottom-up approaches were used to estimate and validate the size of the global market and to estimate the size of various other dependent submarkets in the overall contrast media market. Various secondary sources such as associations like the American College of Radiology (ACR), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), International Society of Radiology (ISR), Radiology Society of North America (RSNA), Journal of Radiology, National Institutes of Health (NIH), International Life Sciences Institute (ILSI), National Kidney Foundation, Organisation for Economic Co-operation and Development (OECD), directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

This research report categorizes the global market into the following segments:

Contrast Media Market, by Type

Barium-based Contrast Media

Iodinated Contrast Media

Gadolinium-based Contrast Media

Microbubble Contrast Media

Contrast Media Market, by Modality

X-ray/Computed Tomography (CT)

Magnetic Resonance Imaging (MRI)

Ultrasound

Contrast Media Market, by Route of Administration

Oral

Intravascular

Rectal

Other Routes

Contrast Media Market, by Indication

Cardiovascular Disorders

Cancer

Gastrointestinal Disorders

Musculoskeletal Disorders

Neurological Disorders

Nephrological Disorders

Contrast Media Market, by Application

Radiology

Interventional Radiology

Interventional Cardiology

Contrast Media Market, by Region

North America

US

Canada

Europe

Germany

UK

France

Rest of Europe (RoE)

Asia Pacific

China

Japan

India

RoAPAC

Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization option is available for the report:

Portfolio Assessment

Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies in the market.

The global contrast media market is projected to reach USD 5.53 Billion by 2022 from an estimated USD 4.57 Billion in 2017, growing at a CAGR of 3.9% during the forecast period. This growth can be attributed to factors such as increasing approvals for contrast agents and growing number of public and private diagnostic centers.

On the basis of type, the market is categorized into barium-based, iodinated contrast media, gadolinium-based, and microbubble-based contrast media. The iodinated contrast media segment is expected to command the largest share of the contrast media market in 2017. The high share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.

On the basis of modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2017, X-ray/CT procedures are expected to command the largest share of the global contrast media market. However, the ultrasound segment is expected to grow at the highest CAGR from 2017 to 2022. Growth in the ultrasound segment can largely be attributed to several advantages offered by ultrasound contrast agents over other contrast agents and the rising number of approvals for ultrasound contrast agents in the US, Europe, and Japan.

On the basis of indication, the market is categorized into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is expected to command the largest share and highest growth rate during the forecast period. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and strong healthcare infrastructure in developed countries are some of the factors driving this segment.

On the basis of route of administration, the market is categorized into oral, intravascular, rectal, and other routes. The intravascular route segment is expected to command the largest share of the contrast media market in 2017. This segment is also expected to grow at the highest CAGR from 2017 to 2022. Growth in this segment can largely be attributed to advancements in CT and MRI imaging technologies that majorly use the intravascular route to inject contrast media.

On the basis application, the market is segmented into radiology, interventional radiology, and interventional cardiology. In 2017, the radiology segment is expected to command the largest share of the global contrast media market. However, the interventional cardiology segment is expected to grow at the highest CAGR from 2017 to 2022. Growth in the interventional cardiology segment can largely be attributed to factors such increasing demand for minimally invasive surgical procedures across the globe and rising burden of cardiovascular diseases.

Geographically, the North American market is expected to account for the largest share of the global contrast media market. The Asia Pacific market is expected to grow at the highest CAGR in the forecast period. This growth can be attributed to the increasing R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries.

Various side effects and allergic reactions associated with the use of contrast media limit the usage of these agents in the medical imaging, thereby restricting the market to some extent.